메뉴 건너뛰기
Lancet Oncology
Volumn 5, Issue 2, 2004, Pages 129-132
Clinical trials with moving targets: A commentary on a non-inferiority trial in testicular cancer
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; ONDANSETRON;
EID: 0742323727     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(04)01389-0     Document Type: Note
Times cited : (8)
References (8)
  • 1
    • 0030939778 scopus 로고    scopus 로고
    • Randomised trial of bleomycin, etoposide and cisplatin compared to bleomycin, etoposide and carboplatin in good prognosis metastatic non-seminomatous germ cell cancer: A multi-institutional MRC/EORTC Trial
    • Horwich A Sleifer D Fossa S et al. Randomised trial of bleomycin, etoposide and cisplatin compared to bleomycin, etoposide and carboplatin in good prognosis metastatic non-seminomatous germ cell cancer: A multi-institutional MRC/EORTC Trial J Clin Oncol 15 1997 1844-1852
    • (1997) J. Clin. Oncol. , vol.15 , pp. 1844-1852
    • Horwich, A.1    Sleifer, D.2    Fossa, S.3
  • 2
    • 0017672542 scopus 로고
    • Cis-diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer
    • Einhorn LH Donohue JP. Cis-diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer Ann Intern Med 87 1977 293-298
    • (1977) Ann. Intern. Med. , vol.87 , pp. 293-298
    • Einhorn, L.H.1    Donohue, J.P.2
  • 3
    • 0026083732 scopus 로고
    • Effectiveness of carboplatin, etoposide and bleomycin combination chemotherapy in good-prognosis metastatic testicular non-seminomatous germ cell tumours
    • Horwich A Dearnaley DP Nicholls J et al. Effectiveness of carboplatin, etoposide and bleomycin combination chemotherapy in good-prognosis metastatic testicular non-seminomatous germ cell tumours J Clin Oncol 9 1991 62-69
    • (1991) J. Clin. Oncol. , vol.9 , pp. 62-69
    • Horwich, A.1    Dearnaley, D.P.2    Nicholls, J.3
  • 4
    • 0742281640 scopus 로고
    • Good risk germ cell tumor (GCT): A randomized trial of etoposide+carboplatin (EC) vs etoposide+cisplatin (EP)
    • Bajorin DF Sarosdy MF Bajorin Bosl GJ Mazumdar M. Good risk germ cell tumor (GCT): a randomized trial of etoposide+carboplatin (EC) vs etoposide+cisplatin (EP) Proc Am Soc Clin Oncol 11 1992 203
    • (1992) Proc. Am. Soc. Clin. Oncol. , vol.11 , pp. 203
    • Bajorin, D.F.1    Sarosdy, M.F.2    Bajorin Bosl, G.J.3    Mazumdar, M.4
  • 5
    • 0001059428 scopus 로고
    • The assessment of subjective opinon and its use in relation to stopping rules for clinical trials
    • Freedman LS Speigelhalter DJ. The assessment of subjective opinon and its use in relation to stopping rules for clinical trials Statistician 32 1983 153-160
    • (1983) Statistician , vol.32 , pp. 153-160
    • Freedman, L.S.1    Speigelhalter, D.J.2
  • 6
    • 0029805578 scopus 로고    scopus 로고
    • Management preferences in stage 1 non-seminomatous germ cell tumours of the testis: An investigation among patients, controls and oncologists
    • Cullen MH Billingham LJ Cook J Woodroffe CM. Management preferences in stage 1 non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists Br J Cancer 74 1996 1487-1491
    • (1996) Br. J. Cancer , vol.74 , pp. 1487-1491
    • Cullen, M.H.1    Billingham, L.J.2    Cook, J.3    Woodroffe, C.M.4
  • 7
    • 0029987569 scopus 로고    scopus 로고
    • Trials to assess equivalence: The importance of rigorous methods
    • Jones B Jarvis P Lewis JA Ebbutt B. Trials to assess equivalence: The importance of rigorous methods BMJ 313 1996 36-39
    • (1996) BMJ , vol.313 , pp. 36-39
    • Jones, B.1    Jarvis, P.2    Lewis, J.A.3    Ebbutt, B.4
  • 8
    • 0027965667 scopus 로고
    • The CHART trials: Bayeisan design and monitoring in practice
    • Parmar MKB Spiegelhalter DJ Freedman LS. The CHART trials: Bayeisan design and monitoring in practice Stat Med 13 1994 1297-1312
    • (1994) Stat. Med. , vol.13 , pp. 1297-1312
    • Parmar, M.K.B.1    Spiegelhalter, D.J.2    Freedman, L.S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.